Extended Data Fig. 5: Changes in circulating cytokine levels from baseline to week 12 by treatment arm. | Nature Medicine

Extended Data Fig. 5: Changes in circulating cytokine levels from baseline to week 12 by treatment arm.

From: Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Extended Data Fig. 5

Changes in circulating cytokine levels from baseline to week 12 by treatment arm. Cytokine analyses were performed using n=54 blood samples from n=27 patients (n=19 patients in nivolumab/ipilimumab with CBM588 arm and n=8 patients in nivolumab/ipilimumab arm). Wilcoxon signed rank test was used to compare cytokine levels across two timepoints.

Source data

Back to article page